VIRUS
STRUCTURE · ROUTE
COURSE
CLUE · MANAGEMENT
+ssRNA naked picornavirus · fecal-oral (shellfish, travel, daycare, MSM)
Acute hepatitis, jaundice (more in adults), never chronic
IgM anti-HAV · vaccine; immune globulin for exposures
+ssRNA naked hepevirus · fecal-oral water, pork, deer
Acute; fulminant in pregnancy (~20% mortality); chronic in transplant patients
Epidemics after monsoon floods
Partly dsDNA hepadnavirus with RT · blood, sex, perinatal
Acute (often subclinical) → chronic risk falls with age at infection; cirrhosis, HCC even without cirrhosis (integration)
Tenofovir, entecavir · vaccine (HBsAg) at birth
Immune complexes
Polyarteritis nodosa, membranous nephropathy, serum-sickness prodrome (rash, arthralgia)
—
+ssRNA flavivirus; no proofreading → quasispecies · IV drugs, transfusion before 1992, tattoos
Mostly asymptomatic acute → chronic in most → cirrhosis, HCC
Anti-HCV screen → HCV RNA confirms · sofosbuvir + NS5A inhibitor (8–12 weeks, > 95% cure)
B-cell stimulation
Mixed cryoglobulinemia, membranoproliferative GN, porphyria cutanea tarda, lichen planus, B-cell lymphoma
Palpable purpura + low C4
Hepatitis D — coinfection
−ssRNA circular, uses HBsAg coat · acquired together with HBV
Usually clears with HBV
IgM anti-HBc ⁺
Hepatitis D — superinfection
HDV on top of chronic HBV
Severe acute flare, rapid progression to cirrhosis
IgG anti-HBc ⁺ · HBV vaccine prevents HDV too
Acute viral hepatitis labs
Hepatocyte necrosis
ALT > AST (often > 1000), ↑ bilirubin
Ballooning degeneration, Councilman bodies
Chronic hepatitis histology
Lymphocytic portal inflammation, interface hepatitis
HBV: ground-glass hepatocytes (HBsAg in ER) · HCV: lymphoid aggregates, steatosis
—
Mother HBsAg ⁺
Infant gets HBV vaccine + HBIG within 12 h
Tenofovir in 3rd trimester if high viral load